Efficacy and safety of valsartan-novasomes in the mitigation of atherosclerosis-associated diabetes mellitus: in vitro and in vivo assessment
{{output}}
Valsartan (VAL) offers protection against atherosclerosis-associated diabetes mellitus (AADM) due to its antioxidant properties. However, VAL is hindered by poor bioavailability and effectiveness, which can be attributed to its low water solubility and signifi... ...
